Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Change in Receivables: 2009-2024

Historic Change in Receivables for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $2.5 million.

  • Lexicon Pharmaceuticals' Change in Receivables rose 923.74% to $1.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $1.0 million, marking a year-over-year increase of 360.91%. This contributed to the annual value of $2.5 million for FY2024, which is 150.81% up from last year.
  • According to the latest figures from FY2024, Lexicon Pharmaceuticals' Change in Receivables is $2.5 million, which was up 150.81% from $982,000 recorded in FY2023.
  • Lexicon Pharmaceuticals' Change in Receivables' 5-year high stood at $2.5 million during FY2024, with a 5-year trough of -$53.2 million in FY2020.
  • Moreover, its 3-year median value for Change in Receivables was $982,000 (2023), whereas its average is $1.2 million.
  • In the last 5 years, Lexicon Pharmaceuticals' Change in Receivables crashed by 205.18% in 2020 and then spiked by 6,914.29% in 2023.
  • Over the past 5 years, Lexicon Pharmaceuticals' Change in Receivables (Yearly) stood at -$53.2 million in 2020, then soared by 99.28% to -$381,000 in 2021, then skyrocketed by 103.67% to $14,000 in 2022, then spiked by 6,914.29% to $982,000 in 2023, then surged by 150.81% to $2.5 million in 2024.